Servicios Personalizados
Revista
Articulo
Indicadores
- Citado por SciELO
- Accesos
Links relacionados
- Similares en SciELO
Compartir
Revista alergia México
versión On-line ISSN 2448-9190
Resumen
HERNANDEZ-MORALES, María del Rocío et al. Frequency of clinical characteristics and factors associated with mortality in patients hospitalized for COVID-19 in Puebla, Mexico. Rev. alerg. Méx. [online]. 2022, vol.69, n.2, pp.67-71. Epub 17-Feb-2023. ISSN 2448-9190. https://doi.org/10.29262/ram.v69i2.1146.
Background:
Mexico has a very high mortality rate from COVID19, risk factors, clinical manifestations of our population are unknown.
Objective:
To know risk factors for mortality from COVID19 in hospitalized patients of the Secretary of Health (SSA) Puebla, and clinical characteristics.
Material and Methods:
Case-control, observational, retrospective, cross-sectional study in COVID-19 patients. 2 groups: COVID-19 patients who died and those who did not die.
Results:
502 patients, 314 men (62.5% CI95% 58-66%), 188 women (37.5% CI95% 33-42%), mean age 54.14 +13.8, interquartile range (IQR) 45-63, age interval 19 and 90 years, hospital stay (DEIH) 1-43 days, mean 9.8+7.8 days, median 8, IQR 4-13 days. Symptoms associated with mortality: dyspnea, chest pain, MR>1. Variables associated with mortality: age = or > 65 years, greater IHD, having > 2 comorbidities (OR 1.453), diabetes (OR 1.759), hypertension (OR 6.29) and chronic kidney failure (CRF) (OR 3.16) , (p<0.05). Ferritin >500ng/ml (OR 5.1799), DHL >400 IU/L (OR 3.313) and D-dimer >2000 m/ml (OR 2.868).
Conclusions:
Age > or = 65 years, greater IHD, > 2 comorbidities, diabetes, hypertension or CRF, increased ferritin, D-dimer or DHL, are risk factors for mortality from COVID-19.
Palabras llave : Coronavirus; SARS-CoV-2; COVID-19; Mortality; Risk factors.